Population toxicokinetics of tetrachloroethylene

Archives of Toxicology

Volumn 70, Issue 6, 1996, Pages 347-355

  Bois, F Y ^a,c   Gelman, A ^b   Jiang, J ^b   Maszle, D R ^b   Zeise, L ^a   Alexeef, G ^a  

^a CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSERM   (France)

Author keywords

Human metabolism; Pharmacokinetics; Population toxicokinetics; Tetrachloroethylene

Indexed keywords

TETRACHLOROETHYLENE;

ARTICLE; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; MODEL; NORMAL HUMAN; PRIORITY JOURNAL; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ADMINISTRATION, INHALATION; ENVIRONMENTAL EXPOSURE; HUMANS; MALE; MODELS, BIOLOGICAL; TETRACHLOROETHYLENE;

EID: 0029976187     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050284     Document Type: Article

References (45)

1. Adolph EF (1949) Quantitative relations in the physiological constitution of mammals. Science 109: 579-585
2. Alexeeff GV, Lewis DC, Zeise L, Cox DN, Schunk HH (1992) Health effects of perchloroethylene. California Department of Health Services, Office of Environmental Health Hazard Assessment, CAL EPA
3. Andersen ME, Krewski D, Withey JR (1993) Physiological pharmacokinetics and cancer risk assessment. Cancer Lett 69: 1-14
4. Åstrand I (1983) Effect of physical exercise on uptake, distribution and elimination of vapors in man. In: Fiserova-Bergerova F (ed) Modeling of inhalation exposure to vapors: uptake, distribution, and elimination. CRC Press, Boca Raton, Florida, pp 107-130
5. Balant LP, Gex-Fabry M (1990) Physiological pharmacokinetic modelling. Xenobiotica 20: 1241-1257
6. Bois FY, Zeise L, Tozer TN (1990) Precision and sensitivity analysis of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats and humans. Toxicol Appl Pharmacol 102: 300-315
7. Bois FY, Woodruff TJ, Spear RC (1991) Comparison of three physiologically-based pharmacokinetic models of benzene disposition. Toxicol Appl Pharmacol 110: 79-88
8. Davidson IWF, Parker JC, Bellies RP (1986) Biological basis for extrapolation across mammalian species. Regul Toxicol Pharmacol 6: 211-237
9. Devroye L (1986) Non-uniform random variate generation. Springer, New York
10. Droz PO, Wu MM, Cumberland WG (1989a) Variability in biological monitoring of organic solvent exposure - II. Application of a population physiological model. Br J Ind Med 46: 547-558
11. Droz PO, Wu MM, Cumberland WG, Berode M (1989b) Variability in biological monitoring of solvent exposure- 1. Development and validation of a population model. Br J Ind Med 46: 447-460
12. Fiserova-Bergerova V (1983) Gases and their solubility: a review of fundamentals. In: Fiserova-Bcrgerova F (ed) Modeling of inhalation exposure to vapors: uptake, distribution, and elimination. CRC Press, Boca Raton, Florida, pp 3-28
13. Gearhart JM, Mahle DA, Greene RJ, Seckel CS, Flemming CD, Fisher JW, Clewell HJ III (1993) Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol Lett 68: 131-144
14. Gelfand AE, Smith AFM (1990) Sampling-based approaches to calculatine marginal densities. J Am Statist Assoc 85: 398-409
15. Gelfand AE, Hills SE, Racine-Poon A, Smith AFM (1990) Illustration of Bayesian inference in normal data models using Gibbs sampling. J Am Statist Assoc 85: 972-985
16. Gelfand AE, Smith AFM, Lee T-M (1992) Bayesian analysis of constrained parameter and truncated data problems using Gibbs sampling. J Am Statist Assoc 87: 523-532
17. Gelman A (1992) Iterative and non-iterative simulation algorithms. Comput Sci Stal 24: 433-438
18. Gelman A (1995) Method of moments using Monte Carlo simulation. J Comput Graphic Stat (in press)
19. Gelman A, Rubin DB (1992) Inference from iterative simulation using multiple sequences (with discussion). Stat Sci 7: 457-511
20. Gerlowski LE, Jain RK (1983) Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci 72: 1103-1127
21. Green T, Odum J, Nash JA, J.R. F (1990) Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans. Toxicol Appl Pharmacol 103: 77-89
22. Guberan E, Fernandez J (1974) Control of industrial exposure to tetrachloroethylene by measuring alveolar concentrations: theoretical approach using a mathematical model. Br J Ind Med 31: 159-167
23. Hattis D, White P, Marmorstein L, Koch P (1990) Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism rates for models derived by different authors. Risk Anal 10: 449-457
24. Ings RM (1990) Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20: 1201-1231
25. International Commission on Radiological Protection (ICRP) (1975) Report of the Task Group on Reference Man - a report prepared by a Task Group of Committee 2 of the International Commission on Radiological Protection. Pergamon Press, Oxford, 480 pp
26. Koizumi A (1989) Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachlorocthylene obtained in rats and man. Br J Ind Med 46: 239-249
27. Monster AC, Boersma G, Steenweg H (1979) Kinetics of tetrachloroethylene in volunteers: influence of exposure concentration and work load. Int Arch Occup Environ Health 42: 303-309
28. Mordenti J (1986) Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci 75: 1028-1040
29. Morgan A, Black A, Belcher DR (1970) The excretion in breath of some aliphatic halogenated hydrocarbons following administration by inhalation. Ann Occup Hyg 13: 219-233
30. Odum J, Green T, Foster JR, Hext PM (1988) The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchlorethylene in the mouse and rat. Toxicol Appl Pharmacol 92: 103-112
31. Opdam JJG (1989) Intra and mterindividual variability in the kinetics of a poorly and highly metabolising solvent. Br J Ind Med 46: 831-845
32. Opdam JJG, Smolders JFJ (1986) Alveolar sampling and fast kinetics of tetrachloroethylene in man. 1 - alveolar sampling. Br J Ind Med 43: 814-824
33. Racine-Poon A, Smith AF (1990) Population models. In: Berry DA (ed) Statistical methodology in the pharmaceutical sciences. Marcel Dekker, New York, pp 139-162
34. Reitz RH (1992) New data on tetrachloroethylene metabolism. OHEEA Advisory Panel Meeting. Cal-EPA, Berkeley
35. Sheiner LB (1984) The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev 15: 153-171
36. Sheiner LB, Ludden TM (1992) Population pharmacokinetics dynamics. Annu Rev Pharmacol Toxicol 32: 185-209
37. Smith AFM (1991) Bayesian computational methods. Philos trans R Soc Lond, Series A 337: 369-386
38. Smith AFM, Wakefield JC (1994) The hierarchical Bayesian approach to population pharmacokinetic modelling. Int J Bio-Med Comput 36: 35-42
39. Tanner MA (1991) Tools for statistical inference - observed data and data augmentation methods. Springer, Berlin
40. Thomas A, Spiegelhalter DJ, Gilks WR (1992) BUGS: a program to perform Bayesian inference using Gibbs sampling. In: Bernardo JM, Berger JO, Dawid AP, Smith AFM (eds.) Bayesian statistics 4, Oxford University Press, Oxford, pp 837-842
41. Wakefield JC, Smith AFM, Racine-Poon A, Gelfand AE (1994) Bayesian analysis of linear and non-linear population models using the Gibbs sampler. Appl Stat- J R Statist Soc Series C 43: 201-221
42. Ward RC, Travis CC, Hetrick DM, Andersen ME, Gargas ML (1988) Pharmacokinetics of tetrachloroethylene. Toxicol Appl Pharmacol 93: 108-117
43. Williams LR, Leggett RW (1989) Reference values for resting blood flow to organs of man. Clin Phys Physiol Measure 10: 187-217
44. Woodruff TJ, Bois FY (1993) Optimization issues in physiological toxicokinetic modeling - a case study with benzene. Toxicol Lett 69: 181-196
45. Woodruff TJ, Bois FY, Auslander D, Spear R (1992) Structure and parametrization of toxicokinetic models: their impact on model predictions. Risk Anal 12: 189-201